Mount Sinai Morningside · 15 hours ago
Postdoctoral Fellow-MSH-32076-156
New York, NY
Full-time
Onsite
New Grad, Entry Level
$72K/yr - $80K/yrMount Sinai Morningside is part of one of the largest academic medical systems in the New York metro area. They are seeking a highly motivated Postdoctoral Fellow to lead projects focused on developing myeloid cell targeted therapies for cancer treatment, requiring a background in immunology and gene engineering.
Hospital & Health Care
Responsibilities
To advance the application of macrophage-targeted CAR T cells
To develop improved ways to arm CAR T cells to remodel the tumor microenvironment
To develop technologies to spatially localize remodeling factors in the tumor microenvironment
Perform independent research in the area of cancer therapy, this will include molecular cloning, vector production, cell isolation, and testing in vivo in preclinical models of different cancers
Critically analyze data quality and results, communicate results to scientists and lay people
Write or assist in writing scientific papers and grants
Collaborate closely with other scientists to conduct research
Qualification
Required
Ph.D. required
Experience working in a research laboratory setting
Company
Mount Sinai Morningside
At Mount Sinai Morningside, we offer exceptional clinical care and research within the comfort of a neighborhood hospital known for compassion and sensitivity.
Founded in 1846
1001-5000 employees
H1B Sponsorship
Mount Sinai Morningside has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageLeadership Team
Faye Reiff-Pasarew
Deputy CMO, Associate Chief of Hospital Medicine, Assistant Professor of Internal Medicine
Lucy Xenophon, MD, MPH
Chief Transformation Officer
Company data provided by crunchbase